OPTIMOL

This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China.

Active ingredients

The drug OPTIMOL contains one active pharmaceutical ingredient (API):

1	Timolol UNII P8Y54F701R - TIMOLOL MALEATE
	Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.
	Read more about Timolol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-3536	Solution/Drops	Optimol Eye Drops SOL_DROPS 0.5%	Ophthalmic Solution Each mL contains: Timolol Maleate equiv. to Timolol base 5 mg, Benzalkonium Chloride Solution 0.0002 mL, Sodium Chloride 1.016 mg, Water Purified Q.S.	28/09/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01ED01	Timolol	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	46551
NG	Registered Drug Product Database	04-3536